Chris Kraneiss is Chief Commercial Officer of Invitrx Therapeutics, where he leads global commercial strategy, distribution and brand growth, including the relaunch of Reluma. He brings more than 20 years of senior leadership in medical aesthetics and professional skincare. At ZO Skin Health he scaled the international business from about $2 million to more than $100 million in revenue across 130+ countries. As Chief Commercial Officer of Elevai Labs he delivered 800% revenue growth, and he has held senior commercial roles at Skinbetter Science and NOON Aesthetics. Chris is known for building executive-level B2B partnerships, international distribution networks and category-defining market positions. He is fluent in English and German and is based in Southern California.